kras mutation and glutathion G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Rerouting the drug response: Overcoming

Rerouting the drug response: Overcoming metabolic adaptation in KRAS mutant cancers Science Signaling Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Uncovering new therapeutic targets for a common KRAS mutation behind cancer

SKU: 77048767325 · From clintoncounty708.com